These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
470 related articles for article (PubMed ID: 20015011)
1. gamma-Secretase as a therapeutic target in Alzheimer's disease. Guardia-Laguarta C; Pera M; Lleó A Curr Drug Targets; 2010 Apr; 11(4):506-17. PubMed ID: 20015011 [TBL] [Abstract][Full Text] [Related]
2. Development and mechanism of γ-secretase modulators for Alzheimer's disease. Crump CJ; Johnson DS; Li YM Biochemistry; 2013 May; 52(19):3197-216. PubMed ID: 23614767 [TBL] [Abstract][Full Text] [Related]
3. Interacting with γ-secretase for treating Alzheimer's disease: from inhibition to modulation. Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Logroscino G; Santamato A; Greco A; Seripa D; Pilotto A Curr Med Chem; 2011; 18(35):5430-47. PubMed ID: 22087836 [TBL] [Abstract][Full Text] [Related]
4. Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease. D'Onofrio G; Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Paroni G; Cascavilla L; Seripa D; Pilotto A Expert Opin Drug Discov; 2012 Jan; 7(1):19-37. PubMed ID: 22468891 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of gamma-secretase inhibitors and modulators. Imbimbo BP Curr Top Med Chem; 2008; 8(1):54-61. PubMed ID: 18220933 [TBL] [Abstract][Full Text] [Related]
7. γ-secretase inhibitors and modulators for the treatment of Alzheimer's disease: disappointments and hopes. Imbimbo BP; Giardina GA Curr Top Med Chem; 2011; 11(12):1555-70. PubMed ID: 21510832 [TBL] [Abstract][Full Text] [Related]
8. BIIB042, a novel γ-secretase modulator, reduces amyloidogenic Aβ isoforms in primates and rodents and plaque pathology in a mouse model of Alzheimer's disease. Scannevin RH; Chollate S; Brennan MS; Snodgrass-Belt PA; Peng H; Xu L; Jung MY; Bussiere T; Arastu MF; Talreja T; Xin Z; Dunstan RW; Fahrer D; Rohde E; Dunah AW; Wang J; Kumaravel G; Taveras AG; Moore Arnold H; Rhodes KJ Neuropharmacology; 2016 Apr; 103():57-68. PubMed ID: 26690893 [TBL] [Abstract][Full Text] [Related]
9. Activity of gamma-secretase on substrates other than APP. Lleó A Curr Top Med Chem; 2008; 8(1):9-16. PubMed ID: 18220928 [TBL] [Abstract][Full Text] [Related]
17. [Development of Alzheimer's disease treatment based on the molecular mechanism of γ-secretase activity]. Tomita T Rinsho Shinkeigaku; 2012; 52(11):1165-7. PubMed ID: 23196551 [TBL] [Abstract][Full Text] [Related]
18. Secretase inhibitors for Alzheimer's disease: challenges of a promiscuous protease. Pollack SJ; Lewis H Curr Opin Investig Drugs; 2005 Jan; 6(1):35-47. PubMed ID: 15675602 [TBL] [Abstract][Full Text] [Related]